Ecor1 Capital, LLC
EcoR1 Capital, LLC is a San Francisco-based hedge fund focused exclusively on biotechnology and life sciences investments. Founded in 2013, the firm manages approximately $5 billion in assets and employs around 21 staff members. EcoR1 serves institutional and accredited investors seeking dedicated exposure to the biotech sector through concentrated, research-driven public equity portfolios.
Investment Strategy
EcoR1 Capital deploys a highly focused strategy investing in publicly traded biotechnology companies, leveraging deep scientific expertise and a disciplined research process. The firm targets overlooked or misunderstood opportunities in the life sciences sector, relying on rigorous due diligence and close engagement with industry experts to identify companies with novel therapies or platforms capable of driving outsized, risk-adjusted returns. EcoR1 typically maintains a concentrated portfolio and seeks to create value by holding investments through fundamental inflection points.
Top Holdings
Equity Positions (36)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
Z ZYME | ZYMEWORKS INC | 17.06% | $288.3M | 22,970,388 | $10.13 | $12.55 | +$82.7M |
A APLS | APELLIS PHARMACEUTICALS INC | 12.19% | $205.9M | 11,895,808 | $43.61 | $17.31 | -$54.2M |
J JAZZ | JAZZ PHARMACEUTICALS PLC | 10.72% | $181.1M | 1,706,469 | $118.51 | $106.12 | -$30.8M |
A ANAB | ANAPTYSBIO INC | 10.36% | $174.9M | 7,880,094 | $19.63 | $22.20 | +$28.4M |
C CRNX | CRINETICS PHARMACEUTICALS IN | 7.30% | $123.3M | 4,288,120 | $37.51 | $28.76 | -$20.5M |
Options Positions (1)
| Ticker | Security | Action | Type | Notional Value | Contracts | Underlying Price | Premium Paid | Change (Contracts) | Change (Value) |
|---|---|---|---|---|---|---|---|---|---|
Q QURE | UNIQURE NV | — | Call | $1.9M | 1,350 | $13.94 | $17.66 | 0 | +$450.9K |